Table 1.
Ideal blocking peptide characteristics
Shortest amino acid sequence disrupting single protein-protein interaction |
Adequate uptake by target cell/tissue |
Short serum half-life |
Prolonged biological half-life |
Minimally antigenic (HLA haplotype matching might reduce antigenicity, especially if repeated peptide doses are administered) |
HLA, human leukocyte antigen.